Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Praecis resubmits Plenaxis NDA

Feb. 28, 2003

Antiangiogenic activity of FYK-1388 demonstrated in vitro and in vivo

Feb. 27, 2003

Orphan medicinal product designation for Corixa's Bexxar product

Feb. 27, 2003

EMEA accepts bortezomib MAA for review

Feb. 27, 2003

Dual inhibitor of Src and Abl kinases SKI-606 exerts potent antileukemic activity

Feb. 26, 2003

Increased antitumor effects of bevacizumab plus 5-FU/leucovorin in colorectal cancer

Feb. 26, 2003

AVI-4126 increases sensitivity of lung tumors to conventional chemotherapeutic agents

Feb. 25, 2003

SB-203580 induces p38 MAP kinase-independent differentiation of leukemia cells

Feb. 25, 2003

Ono-4817 plus docetaxel inhibits lung micrometastasis of MMP-expressing tumor cells in nude mice

Feb. 25, 2003

Enrollment temporarily suspended in phase III studies of tariquidar

Feb. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...